<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662472"><TermName>ABVE regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes  the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, DBVE,  and DBVE regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725931" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ABVE regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725930" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen ABVE&quot;" language="es" id="_4"/><SpanishTermName>régimen ABVE</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa con radioterapia para tratar el linfoma de Hodgkin infantil. Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de vincristina y etopósido. También se llama ABVE, DBVE,  y régimen DBVE.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-05-26</DateFirstPublished><DateLastModified>2010-09-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000681132">ABVE</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
